Literature DB >> 19783332

Ameloblastoma in children and adolescents.

Jing Zhang1, Zexu Gu, Lin Jiang, Jinlong Zhao, Meiyu Tian, Jun Zhou, Yinzhong Duan.   

Abstract

This study first reviewed the data of 37 patients aged 18 years and younger with ameloblastoma over a 16-year period and then reviewed the literature on this subject from 1970 to 2009. Of 37 patients with ameloblastoma, 23 were male and 14 were female, a ratio of 1.6:1. The mean age was 14.8 years. All lesions were in the mandible. Clinical typing included 28 solid type and 9 unicystic type. Ten cases were recurrent (27.0%). A series of literature review disclosed 233 well-documented cases of ameloblastoma in children and adolescents. The ages ranged from 4 to 20 years with a mean age of 14.5 years. The distribution among males and females were almost identical: 53.6% (125/233) males and 46.4% (108/233) females (1.16:1). The mandible was affected in 225 (96.6%), the maxilla in 8 (3.4%). Histologically, solid type (63.1%) predominated over unicystic type (36.9%). Of 226, 123 (54.4%) patients were treated with radical resection, 103 (45.6%) underwent conservative method. Owing to a high recurrent rate of ameloblastoma, solid type of tumors should be approached with radical surgical treatment, while conservative measure can be applied selectively to unicystic type. Long-term follow-up is important because recurrence may appear years after tumor removal.
Copyright © 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19783332     DOI: 10.1016/j.bjoms.2009.08.020

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  15 in total

1.  A review of literature on ameloblastoma in children and adolescents and a rare case report of ameloblastoma in a 3-year-old child.

Authors:  Zainab Chaudhary; Sriram Krishnan; Pankaj Sharma; Rakesh Sharma; Priya Kumar
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-09

2.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

3.  Trends in Pediatric Ameloblastoma and its Management: A 15 year Indian Experience.

Authors:  Neelam N Andrade; Shweta P Shetye; Tejas S Mhatre
Journal:  J Maxillofac Oral Surg       Date:  2012-06-28

4.  Unicystic ameloblastoma with mural proliferation: conservative or surgical approach?

Authors:  Soumi Samuel; Freddy K Mistry; Shilpa Chopra; Ajay Pillai
Journal:  BMJ Case Rep       Date:  2014-08-07

5.  Recurrent unicystic ameloblastoma in a child.

Authors:  Irulandy Ponniah
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

6.  Unicystic ameloblastoma in 3 year old paediatric patient - A rare entity.

Authors:  Shelly Arora; Priya Kumar; Aadithya B Urs; Jeyaseelan Augustine
Journal:  J Clin Exp Dent       Date:  2013-02-01

7.  Incidence and overall survival of malignant ameloblastoma.

Authors:  Alexandra Rizzitelli; Nicolas R Smoll; Michael P Chae; Warren M Rozen; David J Hunter-Smith
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

8.  Conservative management (marsupialization) of unicystic ameloblastoma: literature review and a case report.

Authors:  Jwayoung Kim; Eunkyung Nam; Sukho Yoon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2017-12-25

9.  The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study.

Authors:  M Ruslin; F-N Hendra; A Vojdani; D Hardjosantoso; M Gazali; A Tajrin; J Wolff; T Forouzanfar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-01-01

10.  Recurrence Rates of Intraosseous Ameloblastoma Cases With Conservative or Aggressive Treatment: A Systematic Review and Meta-Analysis.

Authors:  Xue Qiao; Junxiu Shi; Jiayi Liu; Jinwen Liu; Yan Guo; Ming Zhong
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.